Across
- 2. Ultimate way to diagnosis PH
- 4. IV only prostacyclin medication
- 5. CCB not recommended due to potent negative inotropic activity
- 8. Type of PH involving left heart disease, usually HFpEF.
- 9. Unique adverse effect with Bosentan
- 10. Methamphetamines and toxic rapeseed oil association to PAH
- 13. PDE-V inhibitor preferred in advanced CKD
- 16. Trial for untreated PAH using ambrisentan and tadalafil
Down
- 1. PAH risk calculator
- 2. Good oral option if PDEi5 have shown no improvement
- 3. 2 forms required for females to take Riociguat
- 6. Important noninvasive to provide comprehensive information on L/F ventricular anatomy
- 7. Type of PH with pulmonary vascular remodeling and increased resistance, usually PAH
- 11. PH is characterized by a mPAP greater than
- 12. Amount of group classifications of PAH
- 13. Drug class used in HF and PH in left heart disease management
- 14. Treatment option for CTEPH
- 15. Steps to recovery in chronic thromboembolic PH
